Literature DB >> 28848800

Fistulization of J-PEG Jejunal Tube into the Colon in a Patient Treated with Duodopa® Infusion: A Case Report.

Pedro Russo1, Mariana Costa1, Mário Silva1, Ary de Sousa2, Diana Carvalho1, Joana Saiote1, Milena Mendes3.   

Abstract

The continuous delivery of a levodopa/carbidopa gel suspension (Duodopa®) into the small bowel through a jejunal tube inserted via percutaneous endoscopic gastrostomy represents a new treatment method in advanced Parkinson disease. Some severe device-related complications have been described in the last few years. Some of them are associated with phytobezoar formation at the pigtail of the catheter. We present the case of a Parkinson disease patient treated with the Duodopa infusion system complicated by jejunal tube fistulization into the colon. We suggest a possible treatment strategy for this complication, which has not been described in the literature to date.

Entities:  

Keywords:  Antiparkinson agents; Gastrointestinal endoscopy; Gastrostomy/adverse effects; Parkinson disease

Year:  2017        PMID: 28848800      PMCID: PMC5553370          DOI: 10.1159/000452694

Source DB:  PubMed          Journal:  GE Port J Gastroenterol        ISSN: 2387-1954


  7 in total

1.  A clinically silent, but severe, duodenal complication of duodopa infusion.

Authors:  Giovanni Bianco; Giuseppe Vuolo; Monica Ulivelli; Sabina Bartalini; Raffaele Chieca; Alessandro Rossi; Simone Rossi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-04-27       Impact factor: 10.154

2.  Asparagus and jejunal-through-PEG: an unhappy encounter in intrajejunal levodopa infusion therapy.

Authors:  C Schrader; S Böselt; J Wedemeyer; D Dressler; T J Weismüller
Journal:  Parkinsonism Relat Disord       Date:  2010-10-08       Impact factor: 4.891

3.  Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease.

Authors:  D Nyholm; A I M Nilsson Remahl; N Dizdar; R Constantinescu; B Holmberg; R Jansson; S-M Aquilonius; H Askmark
Journal:  Neurology       Date:  2005-01-25       Impact factor: 9.910

4.  Severe gastrointestinal complications in patients with levodopa/carbidopa intestinal gel infusion.

Authors:  Fabian Klostermann; Constanze Jugel; Miriam Bömelburg; Frank Marzinzik; Georg Ebersbach; Thomas Müller
Journal:  Mov Disord       Date:  2012-11       Impact factor: 10.338

5.  Duodopa infusion treatment: a point of view from the gastroenterologist.

Authors:  Lucian Negreanu; Bogdan Ovidiu Popescu; Ruxandra Doina Babiuc; Amalia Ene; Ovidiu Alexandru Bajenaru; Gabriel C Smarandache
Journal:  J Gastrointestin Liver Dis       Date:  2011-09       Impact factor: 2.008

Review 6.  Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implications.

Authors:  C Warren Olanow; Jose A Obeso; Fabrizio Stocchi
Journal:  Lancet Neurol       Date:  2006-08       Impact factor: 44.182

7.  Optimizing levodopa pharmacokinetics: intestinal infusion versus oral sustained-release tablets.

Authors:  Dag Nyholm; Håkan Askmark; Cecilia Gomes-Trolin; Tina Knutson; Hans Lennernäs; Christer Nyström; Sten-Magnus Aquilonius
Journal:  Clin Neuropharmacol       Date:  2003 May-Jun       Impact factor: 1.592

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.